Publications

5891 Results

Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies

Authors
TM Beer;CM Tangen;CR Nichols;KA Margolin;R Dreicer;WT Stephenson;DI Quinn;D Raghavan;ED Crawford
Journal / Conference
Cancer 106(12):2624-2629
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S0207

The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: a multivariate analysis of Southwest Oncology Group study 8894

Authors
TM Beer;CM Tangen;L Bland;M Hussain;BH Goldman;TG DeLoughery;ED Crawford
Journal / Conference
Cancer 107(3):489-496
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Pretreatment CA-125 and risk of relapse in advanced ovarian cancer

Authors
M Markman;PY Liu;M Rothenberg;BJ Monk;M Brady;DS Alberts
Journal / Conference
Journal of Clinical Oncology 24(9):1454-1458
Year
2006
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9326, S9701

Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group study

Authors
HB Grossman;CM Tangen;C Cordon-Cardo;R Cote;FM Waldman;RW De Vere White;AB Karnad;M Glode;ED Crawford
Journal / Conference
Oncology Reports 16:807-810
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9458

Adjuvant radiotherapy for pathologically-advanced prostate cancer: a randomized, clinical trial

Authors
IM Thompson;CM Tangen;J Paradelo;MS Lucia;G Miller;D Troyer;E Messing;J Forman;J Chin;G Swanson;E Canby-Hagino;ED Crawford
Journal / Conference
Journal of the American Medical Association 296(19):2329-2335
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Phase II trial of erlotinib in gastoresophageal junction and gastric adenocarcinomas: SWOG 0127

Authors
T Dragovich;S McCoy;CM Fenoglio-Preiser;J Wang;JK Benedetti;AF Baker;CB Hackett;SG Urba;KS Zaner;CD Blanke;JL Abbruzzese
Journal / Conference
Journal of Clinical Oncology 24(30):4922-4927
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S0127

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I 131 Tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow up of Southwest Oncology Group protocol S9911

Authors
OW Press;JM Unger;RM Braziel;DG Maloney;TP Miller;M LeBlanc;RI Fisher
Journal / Conference
Journal of Clinical Oncology 24(25):4143-4149
Year
2006
Research Committee(s)
Lymphoma
Study Number(s)
S9911

Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group Phase II Trial (S0327)

Authors
PN Lara;K Chansky;AM Davies;WA Franklin;PH Gumerlock;PP Guaglianone;JN Atkins;NC Farneth;PC Mack;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(9):996-1001
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0327

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase

Authors
AR Kristal;C Chi;CM Tangen;PJ Goodman;R Etzioni;IM Thompson
Journal / Conference
Cancer 106(2):320-328
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Phase II trial of paclitaxel, carboplatin and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914

Authors
PJ Hesketh;J McCoy;FR DunphyII;JD Bearden III;GR Weiss;JK Giguere;JN Atkins;SR Dakhil;K Kelly;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(9):991-995
Year
2006
Research Committee(s)
Lung
Study Number(s)
S9914